抗合成酶综合征的共识命名与缩写:一项IMACS项目
本项目由国际肌炎评估与临床研究组(IMACS)批准,基于文献综述和初步调查结果,通过两轮德尔菲调查(分别有来自六大洲、35个国家、9个专科的241名和132名肌炎专家参与)及名义群体技术,指导委员会(含25名肌炎专家和3名患者代表)达成共识:首选命名为「抗合成酶综合征」,首选缩写为ASyS,投票支持率分别为100%和93.1%。
要点
- 共识首选命名为「抗合成酶综合征」,首选缩写为ASyS,投票支持率分别为100%和93.1%。
- 德尔菲调查中ASS、ASyS和ASSD为最常用缩写,但ASS遭到明显反对。
- 建议在研究和临床实践中采用抗合成酶综合征和ASyS作为标准命名与缩写。
核心结论
- 抗合成酶综合征和ASyS应作为研究和临床实践中的标准命名与缩写被采用。
- 该标准化预期将提高文献中的一致性。
研究设计与样本
- 本定性项目由国际肌炎评估与临床研究组(IMACS)批准。
- 基于文献综述和初步调查结果最终确定命名与缩写术语列表。
- 随后在肌炎专家和患者参与者中开展两轮德尔菲调查以明确当前实践和偏好。
- 项目指导委员会采用名义群体技术(NGT)制定共识命名与缩写。
主要发现
- 第一轮和第二轮德尔菲调查分别有来自六大洲、35个国家、9个专科的241名和132名肌炎专家参与。
- 调查结果显示对anti-synthetase syndrome、antisynthetase syndrome和anti-tRNA synthetase syndrome等术语存在偏好。
- ASS、ASyS和ASSD为最常用缩写,但ASS收到明显反对。
- 指导委员会(含25名肌炎专家和3名患者代表)以100%投票支持「抗合成酶综合征」为首选命名,以93.1%投票支持ASyS为首选缩写。
关键数值与推荐
- 首选命名为「抗合成酶综合征」,指导委员会投票支持率100%。
- 首选缩写为ASyS,指导委员会投票支持率93.1%。
临床怎么用
- 作者结论建议在研究和临床实践中采用抗合成酶综合征和ASyS作为标准命名与缩写。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The lack of uniform terminology and abbreviations for anti-synthetase syndrome has led to significant challenges in research and clinical practice. This study aimed to establish an international consensus on a standardized nomenclature and abbreviation among a diverse group of global myositis experts and patient representatives. METHODS: This qualitative project was approved by the International Myositis Assessment and Clinical Studies Group (IMACS). Based on the outcomes of a literature review and preliminary survey, list of terms for nomenclature and abbreviations was finalized. Subsequently, two rounds of the Delphi survey were conducted among myositis experts and patient participants to ascertain current practices and preferences. Using Nominal Group Technique (NGT), the project steering committee developed a consensus nomenclature and abbreviation. RESULTS: A total of 241 and 132 myositis experts from six continents, 35 countries and 9 specialities participated in round 1 and round 2 of the Delphi survey, respectively. The results indicated a preference for the terms anti-synthetase syndrome, antisynthetase syndrome and anti-tRNA synthetase syndrome. The abbreviations ASS, ASyS and ASSD were most used, though ASS received notable disapproval. The steering committee, including twenty-five myositis experts and three patient representatives from diverse backgrounds and geographical locations, reached a consensus on 'anti-synthetase syndrome' as the preferred nomenclature and ASyS as the preferred abbreviation, with 100% and 93.1% votes, respectively. CONCLUSION: The terms anti-synthetase syndrome and ASyS should be adopted as the standard nomenclature and abbreviation in both research and clinical practice. This standardization is expected to increase consistency within the literature.
引用
- Aggarwal A, Chandra T, Keret S, et al. Consensus nomenclature and abbreviation for anti-synthetase syndrome: an IMACS project. Rheumatology (Oxford). 2025. PMID: 40286313. doi:10.1093/rheumatology/keaf229
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。